Scott Henry
Gastroenterology · Erie, PANPI 1871598565
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 135 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Johnson & Johnson accounts for 61.6% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $561 and has fallen 64.5% since, to $199 in 2025.
Across 135 payments — averaging $20.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$461
- Ironwood Pharmaceuticals, Inc$180
- Ferring Pharmaceuticals Inc.$120
- Cook Medical LLC$109
- Celltrion USA Inc.$47
- plus $136 from 5 others
What the payments were for
- Food & beverage$2,69198%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 98 | $1,686 |
| AbbVie | 17 | $461 |
| Ironwood Pharmaceuticals, Inc | 8 | $180 |
| Ferring Pharmaceuticals Inc. | 1 | $120 |
| Cook Medical LLC | 1 | $109 |
| Celltrion USA Inc. | 2 | $47 |
| Boston Scientific | 2 | $45 |
| Organogenesis Inc. | 3 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Pfizer | 1 | $18 |
| Abbott | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,738 in reported general payments places this provider in the 55th percentile of 935 gastroenterology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 19 | $1,886 |
| Pantoprazole Sodium | 43 | $423 |
| Pravastatin Sodium | 11 | $101 |
| Finasteride | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Erie
- Miguel RegueiroPittsburgh$1.5M
- Adam PeytonAllentown$985K
- Shahin RahimianWaynesboro$592K
- Sandra El-HachemPittsburgh$472K
- Harshit KharaDanville$438K
- Kofi ClarkeHershey$426K
- Michael KochmanPhiladelphia$361K
- Gary LichtensteinPhiladelphia$342K
- Elie AounPittsburgh$323K
- Andrew TinsleyHershey$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.